Urgent

Synthetic cannabinoid ("spice") toxicity and agitation

Spice toxicity · Psychiatry / Behavioural
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Synthetic cannabinoid receptor agonists ("spice", "mamba") are potent, unpredictable novel psychoactive substances causing severe agitation, psychosis, catatonia-like states, seizures, tachycardia and occasionally collapse. Potency far exceeds cannabis and effects are not detected on standard drug screens. Management is supportive with benzodiazepine-led sedation.

Red flags

  • Hyperthermia (>39°C) and rigidity
  • Seizures or status epilepticus
  • Reduced GCS or respiratory depression
  • Chest pain or arrhythmia
  • Marked CK elevation (rhabdomyolysis) and AKI

Assessment

Differential diagnosis

  • Other stimulant/NPS intoxication (cathinones, amphetamines)
  • Primary psychosis or mania
  • Organic delirium (sepsis, hypoglycaemia, head injury)
  • Serotonin syndrome or neuroleptic malignant syndrome
  • Alcohol/benzodiazepine withdrawal

Investigations

  • Capillary glucose and continuous observations
  • ECG (tachyarrhythmia, QT)
  • Bloods: U&E, creatine kinase (rhabdomyolysis), FBC, CRP, glucose
  • Venous gas and lactate
  • Temperature monitoring; CT head if reduced GCS or trauma

Management

  • Provide a safe, low-stimulus environment and de-escalate
  • Manage agitation with benzodiazepines, titrated to effect
  • Support airway, breathing and circulation; give oxygen and IV fluids
  • Monitor for hyperthermia, seizures and arrhythmia
  • Check and treat rhabdomyolysis (CK, fluids)
  • Exclude coexisting organic causes and other ingestions
  • Avoid antipsychotics as first line (lower seizure threshold, QT); reserve for refractory psychosis
  • Observe until settled; refer to psychiatry if persistent psychosis

Drugs & doses

Lorazepam — 1-2 mg IM/IV, repeat; max 4 mg/24h with caution (first-line for agitation)
Diazepam — 10 mg IV/PO as alternative, titrate to sedation
Midazolam — 5-10 mg IM/buccal for rapid control with monitoring
IV crystalloid — 0.9% sodium chloride for rhabdomyolysis/dehydration
Haloperidol — 5 mg IM only if refractory psychosis after benzodiazepines, with ECG

Disposition

Observe until agitation and vital signs settle, treat rhabdomyolysis and admit if complications arise; refer to liaison psychiatry if psychosis persists and to substance-misuse services at discharge.

Complications & pitfalls

  • Rhabdomyolysis and acute kidney injury
  • Seizures and hyperthermia
  • Arrhythmia and cardiovascular collapse
  • Persistent psychosis
  • Aspiration and respiratory failure

Exam pearls

  • Standard urine drug screens do not detect synthetic cannabinoids — diagnosis is clinical
  • Potency and contamination are highly variable; small amounts cause severe toxicity
  • Benzodiazepines are first-line for agitation; avoid antipsychotics where possible
  • Always check CK — rhabdomyolysis is common after agitation and restraint
  • Clusters of collapses may signal a contaminated batch — alert public health

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.